Skip to main content Accessibility help
×
Home
Hostname: page-component-684899dbb8-plzwj Total loading time: 0.806 Render date: 2022-05-21T19:12:49.097Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true }

The changing epidemiology worldwide of Mycobacterium ulcerans

Published online by Cambridge University Press:  08 October 2018

D. P. O'Brien*
Affiliation:
Geelong Centre for Emerging Infectious Diseases, Geelong, Australia Department of Medicine and Infectious Diseases, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia Medecins Sans Frontieres, London, UK
I. Jeanne
Affiliation:
School of Medicine, Deakin University, Geelong, Australia
K. Blasdell
Affiliation:
CSIRO Health and Biosecurity, Australian Animal Health Laboratory, Geelong, Australia
M. Avumegah
Affiliation:
Geelong Centre for Emerging Infectious Diseases, Geelong, Australia
E. Athan
Affiliation:
Geelong Centre for Emerging Infectious Diseases, Geelong, Australia
*
Author for correspondence: D. P. O'Brien, E-mail: daniel.obrien@amsterdam.msf.org
Rights & Permissions[Opens in a new window]

Abstract

Mycobacterium ulcerans is recognised as the third most common mycobacterial infection worldwide. It causes necrotising infections of skin and soft tissue and is classified as a neglected tropical disease by the World Health Organization (WHO). However, despite extensive research, the environmental reservoir of the organism and mode of transmission of the infection to humans remain unknown. This limits the ability to design and implement public health interventions to effectively and consistently prevent the spread and reduce the incidence of this disease. In recent years, the epidemiology of the disease has changed. In most endemic regions of the world, the number of cases reported to the WHO are reducing, with a 64% reduction in cases reported worldwide in the last 9 years. Conversely, in a smaller number of countries including Australia and Nigeria, reported cases are increasing at a rapid rate, new endemic areas continue to appear, and in Australia cases are becoming more severe. The reasons for this changing epidemiology are unknown. We review the epidemiology of M. ulcerans disease worldwide, and document recent changes. We also outline and discuss the current state of knowledge on the ecology of M. ulcerans, possible transmission mechanisms to humans and what may be enabling the spread of M. ulcerans into new endemic areas.

Type
Review
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Author(s) 2018

Background

Mycobacterium ulcerans is a slow-growing organism that causes necrotising infections of skin and soft tissue and is classified as a neglected tropical disease by the World Health Organization (WHO) [1]. Ulcers are the most common form of disease, but it can also manifest as a subcutaneous nodule, plaque or as a diffuse and aggressive oedematous form, and can be complicated by osteomyelitis [2Reference Vincent4] (Fig. 1). The disease is known internationally as Buruli ulcer (BU) after the county in Uganda where cases were described in the 1960s. Previously, wide surgical excision was the treatment of choice [Reference Sizaire5], but dual antibiotic combinations have recently been shown to be highly effective at curing lesions [Reference Nienhuis6, Reference Friedman7] and are now the recommended first-line treatment [2, Reference O'Brien8]. Surgery is used to aid wound healing and prevent deformity, or if antibiotics are not tolerated, contraindicated or declined [Reference O'Brien8]. If diagnosed and treated early, outcomes are excellent, but if left untreated, the disease can progress resulting in high levels of morbidity and permanent disability [Reference Vincent4, Reference Ellen9].

Fig. 1. A severe Mycobacterium ulcerans lesion on the knee of an 11-year-old boy.

In Africa, the disease affects mainly children [Reference Vincent4] with more than 50% of cases occurring in those 5 to <15 years of age. Conversely in Australia, it affects mainly adults, with a median age of about 60 years [Reference Tai10]. Nevertheless it can occur in all age groups, is found in males and females equally [Reference Vincent4, Reference Sopoh11, Reference Boyd12], and in Africa it commonly affects those living in remote areas with limited access to health care [Reference Vincent4, 13]. The majority of people affected are overtly immunocompetent, though there appears to be an increased risk in those who are HIV-positive [Reference O'Brien14], and those who are immune suppressed are at risk of developing more severe disease [Reference O'Brien3, Reference Christinet15]. In Africa, the disease occurs most commonly in rural and resource-limited settings where access to safe water and sanitation is low, whilst in Australia, it occurs in high-income settings with access to high-level sanitation and treated water. Sero-epidemiological surveys in Africa suggest that only a small proportion of those exposed to M. ulcerans develop disease [Reference Yeboah-Manu16].

Emergence of BU worldwide

Although an outbreak of skin ulcers resembling BU was reported from Uganda in 1897, the first confirmed reports of BU were from Australia in 1948 in patients residing in the Bairnsdale region in south-eastern Victoria, where it is known as the Bairnsdale ulcer [Reference MacCallum and Tolhurst17]. It has now been reported from 33 countries [1] and is the third most common mycobacterial disease worldwide in immunocompetent people after tuberculosis and leprosy [18] (Table 1 and Fig. 2). Confirmed cases of Buruli were then reported from three countries in the 1950s; Democratic Republic of Congo (DRC) [Reference van Oye and Ballion19], Mexico [Reference Janssens20] and Uganda [Reference Clancey21]. Nine countries across three continents reported their first cases in the 1960s; in Central Africa (Angola [Reference Janssens20], Congo [Reference Perquis and Muret22] and Gabon [Reference Carayon23]), in West Africa (Nigeria) [Reference Janssens20], in Asia and the Pacific (Papua New Guinea [Reference Reid24], Malaysia [Reference Pettit, Marchette and Rees25] and Indonesia [Reference Janssens20]) and in South America (Peru [Reference Janssens20] and French Guiana [Reference Janssens20]). During the 1970s, cases were reported from West Africa for the first time (Benin [Reference Janssens20], Ghana [Reference Bayley26], Sierra Leone [Reference Janssens20] and Cameroon [Reference Ravisse27]). In the 1980s, Ivory Coast [Reference Perraudin, Herrault and Desbois28] and Liberia [Reference Ziefer, Connor and Gybson29] were added to the list of West African countries recording their first cases, along with Japan [Reference Tsukamura30], Kiribati [Reference Christie31] and Suriname [Reference Portaels32]. In the 1990s, four countries were added from West Africa (Burkina Faso [Reference Ouoba33], Equatorial Guinea [Reference Janssens20], Togo [Reference Meyers34] and Guinea [Reference Janssens20]) as well as Sri Lanka [Reference Janssens20] and China [Reference Faber35] from Asia. In the 2000s, Brazil reported cases for the first time [Reference dos Santos36] in addition to the East and Central African countries Kenya [Reference Walsh37], Malawi [Reference Janssens20], South Sudan [Reference Janssens20] and Central African Republic [18].

Fig. 2. Map of countries reporting Buruli ulcer cases, stratified by year of first report. Note that each country is represented by its administrative area and that Buruli ulcer did not occur throughout each country. France is represented for its overseas department French Guiana – there has been no case in metropolitan France.

Table 1. Countries with published reports of Buruli ulcer cases including year of initial report and changes in numbers of cases reported over time

a The presence of M. ulcerans was not microbiologically confirmed in this report.

Current epidemiological situation

The greatest burden of disease is found in West and Central Africa where the highest number of cases are reported from Cote D'Ivoire [Reference Marston39], Benin [Reference Debacker40], Ghana [Reference Amofah41], Cameroon [Reference Noeske42] and the DRC [Reference Kibadi43]. Estimated incidence rates include 21.5 per 100 000/year in parts of Benin [Reference Debacker40] and 20.7 per 100 000/year in Ghana overall with up to 158.8 per 100 000/year in some affected districts [Reference Amofah41]. Cases continue to be reported from South America (mainly in French Guiana) [Reference Douine38, Reference Guerra44, Reference Sambourg45], Asia and the Pacific (mainly in Papua New Guinea) [18,Reference Janssens20]. BU is predominantly found in tropical and subtropical climates, apart from south-eastern Australia [Reference Boyd12, Reference Johnson46] (with estimated incidence rates of up to 404 per 100 000/year) [Reference Fyfe47], China and Japan [Reference Kondo48] (Table 1). In Australia, it has also been reported from tropical areas in Queensland, where it is known as the Daintree ulcer [Reference Jenkin49Reference Francis, Whitby and Woods51], and in the Northern Territory [Reference Quinn and Crotty52]. Importantly, case numbers reported by countries may be influenced by political stability, access to health care, funding for case detection activities, quality of reporting systems and availability of diagnostics. For example, an exhaustive field survey conducted in DRC involving more than 39 000 households showed that only 7% of active BU cases were captured in the hospital-based reporting system [Reference Mavinga Phanzu53].

In recent years, the number of disease cases reported to the WHO worldwide has been steadily decreasing; from 5156 cases in 2008 to 1864 cases in 2016 – a reduction of 64% (Fig. 3). This mainly reflects reductions in Africa where there has been a decline in most of the highest prevalence countries (Table 1). For example, Cote D'Ivoire reported 2679 cases in 2009 and only 376 cases in 2016 (86% reduction), Ghana's reported cases reduced from 1048 in 2010 to 371 in 2016 (65% reduction) and Benin's from 1203 cases in 2007 to 312 in 2016 (74% reduction). An African country going against the trend is Nigeria, where cases were first reported in 2009 and have increased from 24 in that year to 235 in 2016 (879% increase). Case incidence reported from French Guyana has also decreased from 6.07 cases per 100 000 person-years in 1969–1983 to 4.77 cases per 100 000 person-years in 1984–1998 and to 3.49 cases per 100 000 person-years in 1999–2013 [Reference Douine38].

Fig. 3. Number of Buruli ulcer cases worldwide reported to the WHO from 2002 to 2016.

Conversely, in Australia, the number of reported cases has been increasing with 186 reported in 2016 compared with 42 in 2010 (343% increase). This mainly reflects a rapidly increasing number of cases reported from the coastal regions of the south-eastern state of Victoria where there has been a 248% increase in cases in the last 4 years (79 cases in 2014 to 275 in 2017). In this region, the disease has emerged in new geographical areas including the Mornington Peninsula outside of Melbourne, and the proportion of cases presenting with severe disease has doubled since 2010 [Reference Tai10]. Paradoxically, in two adjacent peninsulas separated by only a few kilometres of ocean with similar climate and resident populations, there are diverging epidemics – increasing case numbers on the Mornington Peninsula and reducing case numbers on the Bellarine Peninsula [54].

Ecology of BU

Evidence indicates that M. ulcerans likely evolved from M. marinum by acquiring a virulence plasmid that produces its pathogenic mycolactone toxin [Reference Doig55] and allowed it to adapt to a specific environmental niche [Reference Stinear56]. Laboratory conditions that favour the growth of M. ulcerans are low oxygen [Reference Palomino57], relatively low temperatures (28–33 °C) [Reference Portaels58, Reference Portaels59], moderately acidic environments (pH 5.4–7.4) [Reference Portaels and Pattyn60] and low levels of ultra violet rays [Reference Portaels58]. This may explain why M. ulcerans is often found at the bottom of aquatic habitats or protected by biofilms [Reference Marsollier61]. However, despite extensive research, the environmental reservoir of the organism and mode of transmission of the infection remain unknown. A major factor limiting this understanding is that the organism can rarely be cultured from the environment [Reference Portaels62], although PCR testing of water, aquatic plants, soil and detritus from swamps can show evidence of M. ulcerans [Reference Fyfe47, Reference Ross63Reference Vandelannoote67].

In endemic areas, the disease is highly focal with endemic and non-endemic areas separated by only a few kilometres [Reference Boyd12, 13]. It is usually associated with wetlands, especially those with slow-flowing or stagnant waters such as floodplains or swampy areas [13, Reference Williamson65]. Studies have suggested that farming activities close to rivers [Reference Marston39] and swimming in rivers in endemic areas [Reference Aiga68] are risk factors for acquisition of BU. The construction of dams and irrigation systems have also been associated with increased cases [Reference Marion69], although in French Guyana, a reduction in cases has been observed, likely related to reduced flooding of downstream districts [Reference Morris70]. A major process of land-use change, deforestation, is known to result in increased erosion, which has been speculated to result in run-off contamination of water bodies with M. ulcerans [Reference Hayman71]. Deforestation has also been found to alter the composition of freshwater communities in French Guiana, impacting the abundance of M. ulcerans [Reference Morris72].

In Victoria, Australia, native and domestic mammals including possums, dogs, cats, koalas, horses and alpacas have developed disease [Reference Fyfe47], but whether they are intimately involved in transmission, or accidental hosts, remains unclear. Outside of Australia, M. ulcerans has rarely been detected in vertebrates, although lesions on a wild mouse (Mastomys sp.) from Ghana [Reference Narh73] and on a goat and dog from Benin have been found PCR-positive for M. ulcerans [Reference Zeukeng74], as have domestic duck faeces in Cameroon and wild agouti faeces in Ivory Coast [Reference Bratschi75, Reference Tian76]. In contrast, a range of aquatic invertebrates from numerous taxa representing several orders have been found positive for M. ulcerans DNA from many locations in Africa [Reference Williamson65, Reference Garchitorena77].

Recent evidence from Australia suggests that whatever the source in the environment, it may only persist for a short time [Reference O'Brien78]. In 21 patients with M. ulcerans who were part of a family cluster, the median time to diagnosis between family members was 2.8 months, and none were diagnosed more than 23 months apart in a cohort spanning 18 years and nearly 2000 combined years of elapsed time since diagnosis. This suggests that in this setting the exposure risk is short term, and thereafter diminishes. Environmental studies in Cameroon found that samples from a water hole used by local people remained PCR-positive for more than 2 years, and at least 12 months after all local human M. ulcerans disease cases were treated and cured [Reference Bratschi75]. This suggests that although the risk of disease transmission has diminished, the organism may continue to persist for longer periods in some environments.

Spread of BU into new areas

The mechanism by which M. ulcerans is introduced into new areas is unknown. However in Australia, research using population genomics suggests that the organism has moved from east to west in the southern state of Victoria, and that this relates to the introduction and expansion of M. ulcerans into new environments rather than an awakening of quiescent pathogens [Reference Buultjens79]. Also by analysing the population genomics of isolates from 11 different countries in Africa, Vandelannoote et al. concluded that the spread of M. ulcerans across Africa was a relatively modern phenomenon and one that had escalated since the late 19th and the early 20th centuries [Reference Vandelannoote80]. Their work suggested human-induced changes and activities were behind the expansion of M. ulcerans in Africa with humans with active BU lesions inadvertently contaminating aquatic environments during water contact activities.

In Australia, it is possible that the dispersal of possums or their active transfer by humans from one area to another may promote the introduction of M. ulcerans into new areas. Urban development may also increase the disease risk because possums can reach high population densities in remaining refuge habitats (e.g. parks, ‘bush-style’ gardens) due to their generalist nature and ability to utilise human environments and food sources [Reference Stow81, Reference Giffney, Russell and Kohen82]. Regardless of whether they are directly involved in introducing disease, as possums themselves develop BU, they could act as sentinel animals for detecting the emergence of M. ulcerans disease in new areas in Australia [Reference Carson83].

Transmission of BU to humans

Insects such as mosquitoes [Reference Quek84, Reference Johnson85] and aquatic biting arthropods [Reference Portaels59, Reference Marsollier86] have been proposed as vectors for transmission, but this remains an open question [Reference Benbow66]. Mosquitoes in Australia have tested positive for M. ulcerans by PCR [Reference Johnson85] and there are epidemiological links such as the use of insect repellent on exposed body surfaces and the use of mosquito nets being associated with a reduction in M. ulcerans incidence [Reference Quek84, Reference Landier87]. Additionally, in Australian towns in an endemic area, a strong dose–response relationship was found between the detection of M. ulcerans in mosquitoes and the risk of human disease [Reference Lavender88]. Possible mechanisms for infection may involve direct inoculation of the organism under the skin via a bite, as suggested by a recent study showing that if the skin already surface contaminated with M. ulcerans is subjected to a puncturing injury in the form of a needle or a bite from a live mosquito, then M. ulcerans lesions can develop at the puncture site [Reference Wallace89]. Alternatively, infection may result from a bite leading to a wound which is secondarily infected by M. ulcerans from environmental sources such as soil. Although arguing against this is evidence from a guinea pig model where applying M. ulcerans organisms directly to abraided skin did not establish infection – instead infection was only established when organisms were inoculated under the skin [Reference Williamson90]. It has been proposed that mosquitoes carry the organism on their proboscis following contact or feeding with contaminated environmental sources and then directly transmit it through their bite [Reference Johnson85], although the widespread nature and potential travel of mosquitoes both inside and outside the restricted geographic regions affected by BU argues against this. Nevertheless, it is possible that mosquito movements between the affected and unaffected areas may be limited as some implicated mosquito species, such as Aedes notocsriptus, have short flight distances and low dispersal ability [Reference Foley, Russell and Bryan91], whilst specific larval habitat requirements can also restrict distribution [Reference Johnston92]. If affected mosquito populations in BU endemic areas were relatively isolated from other populations, this could result in the geographic restriction observed.

The strongest evidence for a zoonosis comes from Australia involving native mammal species; the common ringtail (Pseudocheirus peregrinus) and common brushtail (Trichosurus vulpecula) possums. Research has found that 19% of these animals in an endemic area (Point Lonsdale on the Bellarine Peninsula) had M. ulcerans clinical disease, whilst a further 14% were asymptomatic but had high levels of M. ulcerans DNA detected on PCR examination of their faeces [Reference Fyfe47]. In addition, the location, proportion and concentration of M. ulcerans DNA in possum faeces strongly correlated with that of human M. ulcerans disease cases in at least two outbreaks where it has been measured: Sorrento on the Mornington Peninsula [Reference Carson83] and Point Lonsdale on the Bellarine Peninsula [Reference Fyfe47]. Additionally, in nearby areas with no cases of human disease possum faeces were not found to contain M. ulcerans DNA [Reference Fyfe47]. It is theoretically possible that infected possums amplify the organism in the environment [Reference Combe93], leading to an increased risk of infection via contact with a contaminated environment, or an intermediate vector such as a mosquito could mechanically transmit the bacteria from infected possums to humans via a bite. Further research is required to investigate these potential transmission mechanisms and determine if possums play a pivotal role in the transmission of disease to humans or whether they are simply accidental hosts.

In Africa, M. ulcerans has been detected by PCR in aquatic insect species in the order Hemiptera (families: Naucoridae and Belostomatidae), which are known to bite humans, suggesting that transmission may occur through these bites [Reference Portaels59]. This is supported by the detection of M. ulcerans in the salivary glands of these insects after eating snails containing the organism [Reference Marsollier94], and the finding that it can also be transmitted to laboratory mice via their bite [Reference Marsollier86]. In an outbreak in Philip Island, Australia, it was postulated that aerosols generated by spray irrigation using contaminated water may have disseminated M. ulcerans and infected humans via the respiratory tract, or through contamination of skin lesions and minor abrasions [Reference Veitch95], but this has not been proven.

Another recent study on an Australian cohort [Reference O'Brien78] confirms previous suggestions that human-to-human transmission does not occur [Reference Merritt96]. Although cases were often clustered amongst families (6.5% of cases had another family member affected), the short time period between the diagnosis of family clustered cases (median 2.8 months) was shorter than the estimated incubation period of the disease (4.5 months) [Reference O'Brien78]. Additionally, whole genome SNP analysis of isolates from three paired family clusters revealed isolates derived from two of the three family clusters were not genetically identical and family cluster isolates were not any more genetically related than those of six random isolates from the same geographic region [Reference O'Brien78].

The location of clinical M. ulcerans lesions provides some information about possible transmission mechanisms. A study of 649 lesions in 579 Australian patients revealed that most lesions were on exposed body areas, notably upper and lower limbs, and were commonly over a joint. Few lesions were found on the head and neck, palms of hands, soles of feet and trunk [Reference Yerramilli97]. Furthermore, the distribution was non-random, with a strong predilection for ankles, elbows and calves. Differences in the pattern of lesion distribution were also found between genders (men had more lesions on upper limbs and less on lower limbs than women), age groups (those aged ⩾65 years were less likely to have proximal upper limb lesions compared with those <65 years) and season of likely acquisition (lesions on the arm and shoulder were more common amongst those likely acquired in the warmer months). Age, gender and seasonal differences may relate to exposure risk via such mechanisms as trauma, insect bites or soil contact relating to differences in clothing worn or activities undertaken. Similar findings have also been reported from a smaller study in Cameroon [Reference Bratschi98]. Case–control studies in Africa have also identified wearing short lower body clothing whilst farming as risk factors for M. ulcerans [Reference Pouillot99] and covering limbs during farming as protective for M. ulcerans [Reference Kenu100]. These findings suggest that M. ulcerans transmission and pathogenesis may be similar across the world despite very different geographical and climatic conditions.

Transmission also appears to be seasonal. In Australia, the large majority of cases (>70%) are likely acquired in the warmest 6 months of the year [Reference Yerramilli97], and in Cameroon, the likely time of infection was seasonal and highest between the months of August and October [Reference Landier101]. Studies have also reported an association with rainfall; studies from Ghana and Cameroon report that the proportion of M. ulcerans-positive samples from the environment was higher during the months with higher rainfall levels than during the dry season months [Reference Landier101, Reference Aboagye102] and reports from French Guyana [Reference Morris70] and Australia suggest an increase in cases associated with periods of high rainfall followed by dry periods [Reference van Ravensway103].

Future prospects

The epidemiology of M. ulcerans has clearly changed over time and is expected to continue evolving into the future. Although the explanations for this are not fully understood, the processes associated with increasing anthropogenic land-use change such as deforestation, road construction, flooding and population settlement may have significant impacts on this environmental pathogen, affecting both its future distribution and human exposure risk [Reference Combe93]. For example, the increase in cases in recent years observed in south-eastern Victoria, Australia, may be reflective of the impact of new residential developments which may have altered the environment and impacted both aquatic and terrestrial communities, including a proposed reservoir of M. ulcerans, the possum.

Flooding, through environmental disturbance and contamination of aquatic habitats, has regularly been linked to outbreaks of BU [Reference Combe93]. As dams alter the degree and frequency of downstream flooding, the increase in dam building occurring in many regions where BU is endemic, may also alter the distribution of this pathogen. Climate change will likely also be influential, through altered temperatures, increased frequency of extreme weather events and intense flooding events, and inundation of coastal foci, such as the Victorian hot-spot, through changes in sea level. The increased mobility of today's societies may additionally help to modify the distribution of M. ulcerans, by altering the genetic variants of this pathogen present in an area (as found in the Offin river valley in Ghana) [Reference Lamelas104], and by providing opportunities for the establishment of new foci where suitable environmental conditions exist.

Conclusions

The reasons for the changing epidemiology of BU worldwide are unknown. Possibilities include changing environmental conditions such as rainfall and temperature in the era of climate change, changes in population dynamics and land use, improved sanitation and access to healthcare or reduction in exposure through such things as increasing mosquito net use, or spill-over into humans from epidemics in animal reservoirs. Additionally, if humans represent the disease reservoir, it has been speculated that a reduced burden of disease in humans through improved case detection and increasing antibiotic use may be responsible for the reduction in cases in Africa [Reference Vandelannoote80]. However, the situation of increasing cases in Australia, where there is good access to medical care and antibiotic treatment is widely used argues against this explanation. An alternative explanation may be that improvements in the accuracy of diagnosis since PCR confirmation was introduced have reduced over-reporting of cases [Reference O'Brien105].

Importantly, cases of disease have been decreasing in most countries in recent years indicating a hopeful, positive trend. However, despite recent insights, it still has not been conclusively determined how this pathogen circulates in the environment, or how transmission to humans occurs. This requires the availability of robust scientific knowledge acquired by a thorough and exhaustive examination of the environment, local fauna, human behaviour and characteristics, and the interactions between them [Reference O'Brien106]. Only with this knowledge can control strategies or early warning systems be designed and implemented that effectively and consistently prevent the spread and reduce the incidence of this disease.

Conflicts of interest

None.

References

1.World Health Orgainisation (2010) Working to Overcome the Global Impact of Neglected Tropical Diseases: First WHO Report on Neglected Tropical Diseases. Geneva, Switzerland: World Health Orgainisation.Google Scholar
2.World Health Organisation (2012) Treatment of Mycobacterium ulcerans Disease (Buruli Ulcer): Guidance for Health Workers. Geneva, Switzerland: World Health Orgainisation.Google Scholar
3.O'Brien, DP et al. (2014) Clinical features and risk factors of oedematous Mycobacterium ulcerans lesions in an Australian population: beware cellulitis in an endemic area. PLoS Neglected Tropical Diseases 8, e2612.CrossRefGoogle Scholar
4.Vincent, QB et al. (2014) Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study. The Lancet Global Health 2, e422e430.CrossRefGoogle ScholarPubMed
5.Sizaire, V et al. (2006) Mycobacterium ulcerans infection: control, diagnosis, and treatment. The Lancet Infectious Diseases 6, 288296.CrossRefGoogle Scholar
6.Nienhuis, WA et al. (2010) Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial. The Lancet 375, 664672.CrossRefGoogle ScholarPubMed
7.Friedman, ND et al. (2016) Increasing experience with primary oral medical therapy for Mycobacterium ulcerans disease in an Australian cohort. Antimicrobial Agents and Chemotherapy 60, 26922695.CrossRefGoogle Scholar
8.O'Brien, DP et al. (2014) Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update. The Medical Journal of Australia 200, 267270.CrossRefGoogle ScholarPubMed
9.Ellen, DE et al. (2003) Assessment of functional limitations caused by Mycobacterium ulcerans infection: towards a Buruli ulcer functional limitation score. Tropical Medicine & International Health: TM & IH 8, 9096.CrossRefGoogle ScholarPubMed
10.Tai, AYC et al. (2018) Increased severity and spread of Mycobacterium ulcerans, Southeastern Australia. Emerging Infectious Diseases 24, 5864.CrossRefGoogle ScholarPubMed
11.Sopoh, GE et al. (2007) Buruli ulcer surveillance, Benin, 2003–2005. Emerging Infectious Diseases 13, 13741376.CrossRefGoogle ScholarPubMed
12.Boyd, SC et al. (2012) Epidemiology, clinical features and diagnosis of Mycobacterium ulcerans in an Australian population. The Medical Journal of Australia 196, 341344.CrossRefGoogle Scholar
13.Anon (2008) Buruli ulcer: progress report, 2004–2008. Releve epidemiologique hebdomadaire/Section d'hygiene du Secretariat de la Societe des Nations = Weekly Epidemiological Record/Health Section of the Secretariat of the League of Nations 83, 145154.Google Scholar
14.O'Brien, DP et al. (2014) Management of BU-HIV co-infection. Tropical Medicine & International Health: TM & IH 19, 10401047.CrossRefGoogle ScholarPubMed
15.Christinet, V et al. (2014) Impact of HIV on the severity of Buruli ulcer disease: results from a retrospective study in Cameroon. Open Forum Infectious Diseases 1, ofu021.CrossRefGoogle ScholarPubMed
16.Yeboah-Manu, D et al. (2012) Sero-epidemiology as a tool to screen populations for exposure to Mycobacterium ulcerans. PLoS Neglected Tropical Diseases 6, e1460.CrossRefGoogle ScholarPubMed
17.MacCallum, P, Tolhurst, JC et al. (1948) A new mycobacterial infection in man. The Journal of Pathology and Bacteriology 60, 93122.CrossRefGoogle ScholarPubMed
18.World Health Organization. Global Health Observatory data repository - Buruli ulcer. Available at http://apps.who.int/neglected_diseases/ntddata/buruli/buruli.html (accessed 30 June 2018).Google Scholar
19.van Oye, E and Ballion, M (1950) [Is it necessary to take into account a new infection from acid-resistant bacilli in Africa? Preliminary note]. Annales De La Societe Belge De Medecine Tropicale (1920) 30, 619627.Google Scholar
20.Janssens, B et al. (2005) Buruli ulcer: an historical overview with updating to 2005. Bulletin Des Séances Académie Royale Des Sciences D'outre-Mer 51, 265299.Google Scholar
21.Clancey, JK et al. (1961) Mycobacterial skin ulcers in Uganda. The Lancet 2, 951954.CrossRefGoogle ScholarPubMed
22.Perquis, P and Muret, G (1965) [Tropical ulcers due to mycobacteria. Apropos of 2 cases]. Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales 58, 789795.Google Scholar
23.Carayon, A et al. (1968) [Ulcers due to mycobacteria in Africa]. Bulletin De La Societe Medicale D'afrique Noire De Langue Francaise 13, 670679.Google Scholar
24.Reid, IS (1967) Mycobacterium ulcerans infection: a report of 13 cases at the Port Moresby General Hospital, Papua. The Medical Journal of Australia 1, 427431.Google Scholar
25.Pettit, JH, Marchette, NJ and Rees, RJ (1966) Mycobacterium ulcerans infection. Clinical and bacteriological study of the first cases recognized in South East Asia. The British Journal of Dermatology 78, 187197.CrossRefGoogle ScholarPubMed
26.Bayley, AC (1971) Buruli ulcer in Ghana. British Medical Journal 2, 401402.CrossRefGoogle ScholarPubMed
27.Ravisse, P (1977) [Skin ulcer caused by Mycobacterium ulcerans in Cameroon. I. Clinical, epidemiological and histological study]. Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales 70, 109124.Google Scholar
28.Perraudin, ML, Herrault, A and Desbois, JC (1980) [Mycobacterium ulcerans skin ulcers (or Buruli ulcers) (author's transl)]. Annales De Pediatrie 27, 687692.Google Scholar
29.Ziefer, A, Connor, DH and Gybson, DW (1981) Mycobacterium ulcerans: infection of two patients in Liberia. International Journal of Dermatology 20, 362367.CrossRefGoogle ScholarPubMed
30.Tsukamura, M et al. (1989) [A taxonomic study on a mycobacterium which caused a skin ulcer in a Japanese girl and resembled Mycobacterium ulcerans]. Kekkaku: [Tuberculosis] 64, 691697.Google Scholar
31.Christie, M (1987) Suspected Mycobacterium ulcerans disease in Kiribati. The Medical Journal of Australia 146, 600604.Google ScholarPubMed
32.Portaels, F et al. (1996) Variability in 3′ end of 16S rRNA sequence of Mycobacterium ulcerans is related to geographic origin of isolates. Journal of Clinical Microbiology 34, 962965.Google ScholarPubMed
33.Ouoba, K et al. (1998) [Buruli ulcers in Burkina Faso: apropos of 6 cases]. La Tunisie Medicale 76, 4650.Google Scholar
34.Meyers, WM et al. (1996) Mycobacterium ulcerans infection (Buruli ulcer): first reported patients in Togo. The British Journal of Dermatology 134, 11161121.CrossRefGoogle ScholarPubMed
35.Faber, WR et al. (2000) First reported case of Mycobacterium ulcerans infection in a patient from China. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 277279.CrossRefGoogle Scholar
36.dos Santos, VM et al. (2007) Mycobacterium ulcerans infection in Brazil. The Medical Journal of Australia 187, 6364.Google Scholar
37.Walsh, DS et al. (2009) Short report: clinical and molecular evidence for a case of Buruli ulcer (Mycobacterium ulcerans infection) in Kenya. The American Journal of Tropical Medicine and Hygiene 81, 11101113.CrossRefGoogle Scholar
38.Douine, M et al. (2017) Mycobacterium ulcerans infection (Buruli ulcer) in French Guiana, South America, 1969–2013: an epidemiological study. The Lancet Planetary Health 1, e65e73.CrossRefGoogle Scholar
39.Marston, BJ et al. (1995) Emergence of Buruli ulcer disease in the Daloa region of Cote d'Ivoire. The American Journal of Tropical Medicine and Hygiene 52, 219224.CrossRefGoogle ScholarPubMed
40.Debacker, M et al. (2004) Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997–2001. Emerging Infectious Diseases 10, 13911398.CrossRefGoogle ScholarPubMed
41.Amofah, G et al. (2002) Buruli ulcer in Ghana: results of a national case search. Emerging Infectious Diseases 8, 167170.CrossRefGoogle ScholarPubMed
42.Noeske, J et al. (2004) Buruli ulcer disease in Cameroon rediscovered. The American Journal of Tropical Medicine and Hygiene 70, 520526.CrossRefGoogle ScholarPubMed
43.Kibadi, K et al. (2009) [Relapse after surgical treatment of mycobacterium ulcerans infection (Buruli ulcer): study of risk factors in 84 patients in the Democratic Republic of the Congo]. Medecine Tropicale: Revue Du Corps De Sante Colonial 69, 471474.Google Scholar
44.Guerra, H et al. (2008) Mycobacterium ulcerans disease, Peru. Emerging Infectious Diseases 14, 373377.CrossRefGoogle Scholar
45.Sambourg, E et al. (2014) [Paradoxical reactions and responses during antibiotic treatment for Mycobacterium ulcerans infection (Buruli ulcer). Four cases from French Guiana]. Annales De Dermatologie Et De Venereologie 141, 413418.CrossRefGoogle Scholar
46.Johnson, PD et al. (1996) The emergence of Mycobacterium ulcerans infection near Melbourne. The Medical Journal of Australia 164, 7678.CrossRefGoogle ScholarPubMed
47.Fyfe, JA et al. (2010) A major role for mammals in the ecology of Mycobacterium ulcerans. PLoS Neglected Tropical Diseases 4, e791.CrossRefGoogle Scholar
48.Kondo, M et al. (2009) Leg ulcer caused by Mycobacterium ulcerans ssp. shinshuense infection. International Journal of Dermatology 48, 13301333.CrossRefGoogle ScholarPubMed
49.Jenkin, GA et al. (2002) Acute, oedematous Mycobacterium ulcerans infection in a farmer from far North Queensland. The Medical Journal of Australia 176, 180181.Google Scholar
50.Steffen, CM, Smith, M and McBride, WJ (2010) Mycobacterium ulcerans infection in North Queensland: the ‘Daintree ulcer’. ANZ Journal of Surgery 80, 732736.CrossRefGoogle ScholarPubMed
51.Francis, G, Whitby, M and Woods, M (2006) Mycobacterium ulcerans infection: a rediscovered focus in the Capricorn Coast region of central Queensland. The Medical Journal of Australia 185, 179180.Google ScholarPubMed
52.Quinn, JV and Crotty, JM (1963) Mycobacterium ulcerans infections in the Northern Territory. The Medical Journal of Australia 2, 317319.Google ScholarPubMed
53.Mavinga Phanzu, D et al. (2013) Burden of Mycobacterium ulcerans disease (Buruli ulcer) and the underreporting ratio in the territory of Songololo, Democratic Republic of Congo. PLoS Neglected Tropical Diseases 7, e2563.CrossRefGoogle ScholarPubMed
54.Department of Human Services Victoria. Surveillance of notifiable conditions in Victoria – regional comparisons. Available at http://www.health.vic.gov.au/ideas/downloads/daily_reports/rptVS_SNIDSRegionalComparisons_GR.pdf (accessed 1 March 2018).Google Scholar
55.Doig, KD et al. (2012) On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer. BMC Genomics 13, 258.CrossRefGoogle ScholarPubMed
56.Stinear, TP et al. (2007) Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer. Genome Research 17, 192200.CrossRefGoogle ScholarPubMed
57.Palomino, J et al. (1998) Effect of oxygen on growth of Mycobacterium ulcerans in the BACTEC system. Journal of Clinical Microbiology 36, 34203422.Google ScholarPubMed
58.Portaels, F et al. (2001) Mycobacterium ulcerans in wild animals. Revue Scientifique Et Technique (International Office of Epizootics) 20, 252264.Google ScholarPubMed
59.Portaels, F et al. (1999) Insects in the transmission of Mycobacterium ulcerans infection. The Lancet 353, 986.CrossRefGoogle ScholarPubMed
60.Portaels, F and Pattyn, SR (1982) Growth of mycobacteria in relation to the pH of the medium. Annales De Microbiologie 133, 213221.Google Scholar
61.Marsollier, L et al. (2007) Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. PLoS Pathogens 3, e62.CrossRefGoogle ScholarPubMed
62.Portaels, F et al. (2008) First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Neglected Tropical Diseases 2, e178.CrossRefGoogle ScholarPubMed
63.Ross, BC et al. (1997) Detection of Mycobacterium ulcerans in environmental samples during an outbreak of ulcerative disease. Applied and Environmental Microbiology 63, 41354138.Google ScholarPubMed
64.Stinear, T et al. (1999) Identification and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR. Journal of Clinical Microbiology 37, 10181023.Google ScholarPubMed
65.Williamson, HR et al. (2008) Distribution of Mycobacterium ulcerans in Buruli ulcer endemic and non-endemic aquatic sites in Ghana. PLoS Neglected Tropical Diseases 2, e205.CrossRefGoogle ScholarPubMed
66.Benbow, ME et al. (2008) Aquatic invertebrates as unlikely vectors of Buruli ulcer disease. Emerging Infectious Diseases 14, 12471254.CrossRefGoogle ScholarPubMed
67.Vandelannoote, K et al. (2010) Application of real-time PCR in Ghana, a Buruli ulcer-endemic country, confirms the presence of Mycobacterium ulcerans in the environment. FEMS Microbiology Letters 304, 191194.CrossRefGoogle ScholarPubMed
68.Aiga, H et al. (2004) Assessing water-related risk factors for Buruli ulcer: a case-control study in Ghana. The American Journal of Tropical Medicine and Hygiene 71, 387392.CrossRefGoogle ScholarPubMed
69.Marion, E et al. (2011) Geographic expansion of Buruli ulcer disease, Cameroon. Emerging Infectious Diseases 17, 551553.CrossRefGoogle ScholarPubMed
70.Morris, A et al. (2014) Complex temporal climate signals drive the emergence of human water-borne disease. Emerging Microbes & Infections 3, e56e56.CrossRefGoogle ScholarPubMed
71.Hayman, J (1991) Postulated epidemiology of Mycobacterium ulcerans infection. International Journal of Epidemiology 20, 10931098.CrossRefGoogle ScholarPubMed
72.Morris, AL et al. (2016) Deforestation-driven food-web collapse linked to emerging tropical infectious disease, Mycobacterium ulcerans. Science Advances 2, e1600387.CrossRefGoogle ScholarPubMed
73.Narh, CA et al. (2015) Source tracking Mycobacterium ulcerans infections in the Ashanti region, Ghana. PLoS Neglected Tropical Diseases 9, e0003437.CrossRefGoogle ScholarPubMed
74.Zeukeng, F (2017) Mycobacterium ulcerans infected wounds found in domestic animals in the Buruli ulcer endemic area of Sedje-Denou, Southern Benin. In World Health Organization annual scientific meeting on Buruli ulcer. Geneva, Switzerland.Google Scholar
75.Bratschi, MW et al. (2014) Mycobacterium ulcerans persistence at a village water source of Buruli ulcer patients. PLoS Neglected Tropical Diseases 8, e2756.CrossRefGoogle Scholar
76.Tian, RB et al. (2016) Detection of Mycobacterium ulcerans DNA in the environment, Ivory Coast. PLoS ONE 11, e0151567.CrossRefGoogle ScholarPubMed
77.Garchitorena, A et al. (2014) Mycobacterium ulcerans ecological dynamics and its association with freshwater ecosystems and aquatic communities: results from a 12-month environmental survey in Cameroon. PLoS Neglected Tropical Diseases 8, e2879.CrossRefGoogle ScholarPubMed
78.O'Brien, DP et al. (2017) Exposure risk for infection and lack of human-to-human transmission of Mycobacterium ulcerans disease, Australia. Emerging Infectious Diseases 23, 837840.CrossRefGoogle Scholar
79.Buultjens, AH et al. (2018) Comparative genomics shows Mycobacterium ulcerans migration and expansion has preceded the rise of Buruli ulcer in south-eastern Australia. Applied and Environmental Microbiology 84, e02612-17.CrossRefGoogle Scholar
80.Vandelannoote, K et al. (2017) Multiple introductions and recent spread of the emerging human pathogen Mycobacterium ulcerans across Africa. Genome Biology and Evolution 9, 414426.Google ScholarPubMed
81.Stow, A et al. (2006) Genetic structure infers generally high philopatry and male-biased dispersal of brushtail possums (‘Trichosurus vulpecula’) in urban Australia. Wildlife Research 33, 409415.CrossRefGoogle Scholar
82.Giffney, R, Russell, T and Kohen, J (2009) Age of road-killed common brushtail possums (Trichosurus vulpecula) and common ringtail possums (Pseudocheirus peregrinus) in an urban environment. Australian Mammalogy 31, 137142.CrossRefGoogle Scholar
83.Carson, C et al. (2014) Potential wildlife sentinels for monitoring the endemic spread of human Buruli ulcer in South-East Australia. PLoS Neglected Tropical Diseases 8, e2668.CrossRefGoogle ScholarPubMed
84.Quek, TY et al. (2007) Risk factors for Mycobacterium ulcerans infection, southeastern Australia. Emerging Infectious Diseases 13, 16611666.CrossRefGoogle ScholarPubMed
85.Johnson, PD et al. (2007) Mycobacterium ulcerans in mosquitoes captured during outbreak of Buruli ulcer, southeastern Australia. Emerging Infectious Diseases 13, 16531660.CrossRefGoogle ScholarPubMed
86.Marsollier, L et al. (2002) Aquatic insects as a vector for Mycobacterium ulcerans. Applied and Environmental Microbiology 68, 46234628.CrossRefGoogle ScholarPubMed
87.Landier, J et al. (2011) Adequate wound care and use of bed nets as protective factors against Buruli ulcer: results from a case control study in Cameroon. PLoS Neglected Tropical Diseases 5, e1392.CrossRefGoogle ScholarPubMed
88.Lavender, CJ et al. (2011) Risk of Buruli ulcer and detection of Mycobacterium ulcerans in mosquitoes in southeastern Australia. PLoS Neglected Tropical Diseases 5, e1305.CrossRefGoogle ScholarPubMed
89.Wallace, JR et al. (2017) Mycobacterium ulcerans low infectious dose and mechanical transmission support insect bites and puncturing injuries in the spread of Buruli ulcer. PLoS Neglected Tropical Diseases 11, e0005553.CrossRefGoogle ScholarPubMed
90.Williamson, HR et al. (2014) Mycobacterium ulcerans fails to infect through skin abrasions in a guinea pig infection model: implications for transmission. PLoS Neglected Tropical Diseases 8, e2770.CrossRefGoogle Scholar
91.Foley, DH, Russell, RC and Bryan, JH (2004) Population structure of the peridomestic mosquito Ochlerotatus notoscriptus in Australia. Medical and Veterinary Entomology 18, 180190.CrossRefGoogle ScholarPubMed
92.Johnston, E et al. (2014) Mosquito communities with trap height and urban-rural gradient in Adelaide, South Australia: implications for disease vector surveillance. Journal of Vector Ecology: Journal of the Society for Vector Ecology 39, 4855.CrossRefGoogle ScholarPubMed
93.Combe, M et al. (2017) Global and local environmental changes as drivers of Buruli ulcer emergence. Emerging Microbes & Infections 6, e22.Google ScholarPubMed
94.Marsollier, L et al. (2004) Aquatic snails, passive hosts of Mycobacterium ulcerans. Applied and Environmental Microbiology 70, 62966298.CrossRefGoogle ScholarPubMed
95.Veitch, MG et al. (1997) A large localized outbreak of Mycobacterium ulcerans infection on a temperate southern Australian island. Epidemiology and Infection 119, 313318.CrossRefGoogle ScholarPubMed
96.Merritt, RW et al. (2010) Ecology and transmission of Buruli ulcer disease: a systematic review. PLoS Neglected Tropical Diseases 4, e911.CrossRefGoogle ScholarPubMed
97.Yerramilli, A et al. (2017) The location of Australian Buruli ulcer lesions – implications for unravelling disease transmission. PLoS Neglected Tropical Diseases 11, e0005800.CrossRefGoogle ScholarPubMed
98.Bratschi, MW et al. (2013) Geographic distribution, age pattern and sites of lesions in a cohort of Buruli ulcer patients from the Mape Basin of Cameroon. PLoS Neglected Tropical Diseases 7, e2252.CrossRefGoogle Scholar
99.Pouillot, R et al. (2007) Risk factors for Buruli ulcer: a case control study in Cameroon. PLoS Neglected Tropical Diseases 1, e101.CrossRefGoogle ScholarPubMed
100.Kenu, E et al. (2014) Risk factors for Buruli ulcer in Ghana – a case control study in the Suhum-Kraboa-Coaltar and Akuapem South Districts of the eastern region. PLoS Neglected Tropical Diseases 8, e3279.CrossRefGoogle Scholar
101.Landier, J et al. (2015) Seasonal patterns of Buruli ulcer incidence, Central Africa, 2002–2012. Emerging Infectious Diseases 21, 14141417.CrossRefGoogle ScholarPubMed
102.Aboagye, SY et al. (2017) Seasonal pattern of Mycobacterium ulcerans, the Causative Agent of Buruli ulcer, in the environment in Ghana. Microbial Ecology 74, 350361.CrossRefGoogle ScholarPubMed
103.van Ravensway, J et al. (2012) Climate and landscape factors associated with Buruli ulcer incidence in Victoria, Australia. PLoS ONE 7, e51074.CrossRefGoogle ScholarPubMed
104.Lamelas, A et al. (2016) Spatiotemporal co-existence of two Mycobacterium ulcerans clonal complexes in the Offin River Valley of Ghana. PLoS Neglected Tropical Diseases 10, e0004856.CrossRefGoogle ScholarPubMed
105.O'Brien, DP (2017) Unlocking of the secrets of Mycobacterium ulcerans disease transmission. The Lancet Planetary Health 1, e52e53.CrossRefGoogle ScholarPubMed
106.O'Brien, DP et al. (2018) Tackling the worsening epidemic of Buruli ulcer in Australia in an information void: time for an urgent scientific response. The Medical Journal of Australia 208, 287289.CrossRefGoogle Scholar
Figure 0

Fig. 1. A severe Mycobacterium ulcerans lesion on the knee of an 11-year-old boy.

Figure 1

Fig. 2. Map of countries reporting Buruli ulcer cases, stratified by year of first report. Note that each country is represented by its administrative area and that Buruli ulcer did not occur throughout each country. France is represented for its overseas department French Guiana – there has been no case in metropolitan France.

Figure 2

Table 1. Countries with published reports of Buruli ulcer cases including year of initial report and changes in numbers of cases reported over time

Figure 3

Fig. 3. Number of Buruli ulcer cases worldwide reported to the WHO from 2002 to 2016.

You have Access
Open access
8
Cited by

Save article to Kindle

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

The changing epidemiology worldwide of Mycobacterium ulcerans
Available formats
×

Save article to Dropbox

To save this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about saving content to Dropbox.

The changing epidemiology worldwide of Mycobacterium ulcerans
Available formats
×

Save article to Google Drive

To save this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about saving content to Google Drive.

The changing epidemiology worldwide of Mycobacterium ulcerans
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *